Experienced in Primary Immunodeficiency (PID)

Paul K. Keith

3V47 HSC 1280 Main St W, 
Hamilton, ON, CA 
Experienced in Primary Immunodeficiency (PID)
3V47 HSC 1280 Main St W, 
Hamilton, ON, CA 
OverviewLocationsClinical Research

Overview

Paul Keith practices in Hamilton, Canada. Mr. Keith is rated as an Experienced expert by MediFind in the treatment of Primary Immunodeficiency (PID). His top areas of expertise are Angioedema, Hereditary Angioedema, Hives, and Allergic Rhinitis.

His clinical research consists of co-authoring 48 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles and participated in 2 clinical trials in the study of Primary Immunodeficiency (PID).

Gender
Male

Locations

3V47 HSC 1280 Main St W, Hamilton, ON L8S4K1, Canada
Other Locations
HSC Room 2C16, 1280 Main Street West Hamilton, Hamilton, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

An Observational, Non-interventional, Study of Patients With Hereditary Angioedema in the United States and Canada (EMPOWER Study)
An Observational, Non-interventional, Study of Patients With Hereditary Angioedema in the United States and Canada (EMPOWER Study)
Enrollment Status: Completed
Publish Date: March 30, 2023
An Open-Label, Single-Arm, Historically Controlled, Prospective, Multicenter Phase III Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Immune Globulin Intravenous (Human) GC5107 in Subjects With Primary Humoral Immunodeficiency
An Open-Label, Single-Arm, Historically Controlled, Prospective, Multicenter Phase III Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Immune Globulin Intravenous (Human) GC5107 in Subjects With Primary Humoral Immunodeficiency
Enrollment Status: Completed
Publish Date: December 09, 2022
Intervention Type: Biological
Study Phase: Phase 3
Real-world CANadian CUvitru Non-Interventional Study in Subjects Transitioning From Subcutaneous Immunoglobulin (CANCUN)
Real-world CANadian CUvitru Non-Interventional Study in Subjects Transitioning From Subcutaneous Immunoglobulin (CANCUN)
Enrollment Status: Completed
Publish Date: March 05, 2021
Intervention Type: Biological
View 2 Less Clinical Trials

48 Total Publications

Comorbidities in Canadian patients with hereditary angioedema: a quantitative survey study.
Comorbidities in Canadian patients with hereditary angioedema: a quantitative survey study.
Journal: Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology
Published: November 22, 2024

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Keith's expertise for a condition
ConditionClose
    View All 10 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile